Sarcoma PDX Models

Patient derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agents efficacy prior to entering the clinic. The CrownBio collection contains many sarcoma PDX models of both North American and Asian decent for a true representation of the variability found in the patient population. More

Patient-derived xenografts (PDX) offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. CrownBio’s HuPrime® PDX collection well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL ID CANCER TYPE SUBTYPE models per page
SA0271 Sarcoma Spindle cell carcinoma VIEW MODEL Details
SA0319 Sarcoma Spindle cell carcinoma VIEW MODEL Details
SA0639 Sarcoma rhabdomyosarcoma VIEW MODEL Details
SA0666 Sarcoma Spindle cell carcinoma VIEW MODEL Details
SA10132 Sarcoma Sarcoma VIEW MODEL Details
SA10139 Sarcoma NA VIEW MODEL Details
SA10145 Sarcoma Sarcoma VIEW MODEL Details
SA10146 Sarcoma NA VIEW MODEL Details
SA10151 Sarcoma NA VIEW MODEL Details
SA10153 Sarcoma Sarcoma VIEW MODEL Details